Order Article Reprints

Nakagami H, Matsumoto T, Takazawa K, Sekino H, Matsuoka O, Inoue S, Furuie H, Morishita R. Long Term Follow-Up Study of a Randomized, Open-Label, Uncontrolled, Phase I/II Study to Assess the Safety and Immunogenicity of Intramuscular and Intradermal Doses of COVID-19 DNA Vaccine (AG0302-COVID19). Vaccines. 2023; 11(10):1535. https://doi.org/10.3390/vaccines11101535

Nakagami, Hironori, Tetsuya Matsumoto, Kenji Takazawa, Hisakuni Sekino, Osamu Matsuoka, Satoshi Inoue, Hidetoshi Furuie, and Ryuichi Morishita. 2023. "Long Term Follow-Up Study of a Randomized, Open-Label, Uncontrolled, Phase I/II Study to Assess the Safety and Immunogenicity of Intramuscular and Intradermal Doses of COVID-19 DNA Vaccine (AG0302-COVID19)" Vaccines 11, no. 10: 1535. https://doi.org/10.3390/vaccines11101535

Nakagami, H., Matsumoto, T., Takazawa, K., Sekino, H., Matsuoka, O., Inoue, S., Furuie, H., & Morishita, R. (2023). Long Term Follow-Up Study of a Randomized, Open-Label, Uncontrolled, Phase I/II Study to Assess the Safety and Immunogenicity of Intramuscular and Intradermal Doses of COVID-19 DNA Vaccine (AG0302-COVID19). Vaccines, 11(10), 1535. https://doi.org/10.3390/vaccines11101535